Fig. 2

Development of the mean number of necessary IOP-lowering medication over the course of two years after TE or PF implantation. IOP, intraocular pressure; TE, trabeculectomy; PF, PRESERFLO
Development of the mean number of necessary IOP-lowering medication over the course of two years after TE or PF implantation. IOP, intraocular pressure; TE, trabeculectomy; PF, PRESERFLO